0001209191-20-026617.txt : 20200501 0001209191-20-026617.hdr.sgml : 20200501 20200501180015 ACCESSION NUMBER: 0001209191-20-026617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200429 FILED AS OF DATE: 20200501 DATE AS OF CHANGE: 20200501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS STEPHEN CENTRAL INDEX KEY: 0001131146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 20842133 MAIL ADDRESS: STREET 1: NEUROGEN CORP STREET 2: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-29 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001131146 DAVIS STEPHEN C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, STE. 300 SAN DIEGO CA 92130 1 1 0 0 CEO Common Stock 2020-04-29 4 M 0 15625 A 18579 D Common Stock 2020-04-30 4 S 0 6770 49.21 D 11809 D Restricted Stock Units 2020-04-29 4 M 0 15625 0.00 D Common Stock 15625 46875 D Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. The restricted stock units vest in four equal annual installments beginning 4/29/2020. /s/ Austin D. Kim, Attorney-in-Fact 2020-05-01